Compare Ecolab Inc. (ECL) vs Inovio Pharmaceuticals Inc (INO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Ecolab Inc. vs Inovio Pharmaceuticals Inc — how do they compare? Ecolab Inc. trades at $285 (market cap $79.79B), while Inovio Pharmaceuticals Inc trades at $0.77 (market cap $78.55M). The key difference: Ecolab Inc. is far larger — about 1015.8× Inovio Pharmaceuticals Inc's market cap, and Ecolab Inc. pays a 1.03% dividend while Inovio Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| ECL | INO | |
|---|---|---|
Market Cap | $79.79B | $78.55M |
Sector | Consumer Cyclical | Health |
52-Week High | $308.35 | $2.87 |
52-Week Low | $245.73 | $0.66 |
Enterprise Value | $88.57B | $49.56M |
Dividend Yield | 1.03% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Ecolab Inc.
Ecolab produces and markets cleaning and sanitation products for the hospitality, healthcare, and industrial markets. The firm is the global market share leader in this category with a wide array of products and services, including dish and laundry washing systems, pest control, and infection control products. The company has a strong hold on the U.S. market and is looking to increase its profitability abroad. Additionally, Ecolab serves customers in water, manufacturing, and life sciences end markets, selling customized solutions.
Read more on ECL →About Inovio Pharmaceuticals Inc
Inovio Pharmaceuticals Inc is a United States based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.
Read more on INO →
